NHPClass II
Analyzer, Gas, Sevoflurane, Gaseous-Phase (Anesthetic Concentration)
21 CFR 868.1500 / Anesthesiology
NHP is the FDA product code for Analyzer, Gas, Sevoflurane, Gaseous-Phase (Anesthetic Concentration), a class II device type, regulated under 21 CFR 868.1500. FDA's definition for this code reads: "A sevoflurane gas analyzer is a device intended to measure the concentration of sevoflurane anesthetic in a gas mixture". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- NHP
- Device name
- Analyzer, Gas, Sevoflurane, Gaseous-Phase (Anesthetic Concentration)
- FDA definition
- A sevoflurane gas analyzer is a device intended to measure the concentration of sevoflurane anesthetic in a gas mixture
- Regulation
- 21 CFR 868.1500
- Device class
- Class II
- Review panel
- Anesthesiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code NHP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2004 | 1 |
Applicants with the most clearances
Product code NHP| Applicant | Clearances |
|---|---|
| Draeger Medical Systems, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- AD Supply Group Limited
- Amphenol Cable and Interconnect Technologies Asia Pacific Ltd.
- Amphenol Medical Technologies (Dongguan) Co., Ltd.
- Caf Medical Solutions Inc
- CBR Enterprise Limited
- Change Healthcare Canada Company
- Datascope Corp.
- DHL Supply Chain (Netherlands) B.V.
- Draeger Medical Systems, Inc.
- Draegerwerk AG & Co. KGaA
- DRE Med
- EDAN Diagnostics, Inc.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
